R. Manchanda

发表

Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1/2 carriers

I. Jacobs, U. Menon, C. Jacobs, 2010, Familial Cancer.

A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer

J. Cuzick, I. Dos Santos Silva, J. Hopper, 2019, JAMA oncology.

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing

J. Wardle, I. Jacobs, U. Menon, 2014, Journal of the National Cancer Institute.

The need for accredited training in gynaecological oncology: a report from the European Network of Young Gynaecological Oncologists (ENYGO).

M. Burnell, P. Zola, N. Colombo, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Differential diagnosis of adnexal masses : A sequential use of the Risk of Malignancy Index and a novel computer aided diagnostic tool.

U. Menon, R. Manchanda, H. Bleiberg, 2012 .

Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women

A. Antoniou, I. Jacobs, U. Menon, 2017, American journal of obstetrics and gynecology.

Laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovary syndrome.

R. Manchanda, A. Kriplani, N. Agarwal, 2001, The Journal of the American Association of Gynecologic Laparoscopists.

Population-based genetic testing for Women's cancer prevention.

R. Manchanda, Olivia Evans, F. Gaba, 2020, Best practice & research. Clinical obstetrics & gynaecology.

BRCA-carrier identification offers opportunities for early-diagnoses, targeted treatment and cancer prevention. We evaluate BRCA-carrier detection rates in General and Ashkenazi-Jewish(AJ) populations across Greater-London and estimate time-to-detection of all identifiable BRCA-carriers. Methods BRC

V. S. Gordeev, A. Antoniou, I. Jacobs, 2018 .

Genetic testing for gynaecological cancer

R. Manchanda, F. Gaba, 2017 .

Diet, physical activity, and health-related outcomes of endometrial cancer survivors in a behavioral lifestyle program: the Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomized controlled pilot trial

M. Burnell, R. Beeken, D. Koutoukidis, 2019, International Journal of Gynecologic Cancer.

Population-based Genetic Testing for Precision Prevention

R. Manchanda, Olivia Evans, 2020, Cancer Prevention Research.

Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study

U. Menon, Naveena Singh, D. Evans, 2020, Journal of Medical Genetics.

Population Screening for Inherited Predisposition to Breast and Ovarian Cancer.

A. Lahad, E. Levy-Lahad, S. Lieberman, 2020, Annual review of genomics and human genetics.

Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers.

R. Manchanda, F. Gaba, 2020, Best practice & research. Clinical obstetrics & gynaecology.

Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial

U. Menon, M. Burnell, Naveena Singh, 2020, International Journal of Gynecological Cancer.

Screening of symptomatic women for ovarian cancer.

U. Menon, A. Gentry-Maharaj, M. Burnell, 2012, The Lancet. Oncology.

Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma

A. Talhouk, S. Leung, A. Bashashati, 2020, Clinical Cancer Research.

Methotrimeprazine in the treatment of agitation in acquired brain injury patients.

R. Manchanda, O. Maryniak, A. Velani, 2001, Brain injury.

Impact of SARS-CoV-2 on training and mental well-being of surgical gynecological oncology trainees

A. Pletnev, K. Zalewski, M. Lanner, 2021, International Journal of Gynecological Cancer.

A randomized trial of danazol pretreatment prior to endometrial resection.

R. Manchanda, A. Kriplani, D. Takkar, 2002, European journal of obstetrics, gynecology, and reproductive biology.

Depot Medroxy Progesterone Acetate: A Poor Preparatory Agent for Endometrial Resection

R. Manchanda, A. Kriplani, D. Takkar, 2001, Gynecologic and Obstetric Investigation.

Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER‐2 cohort study

R. Glasspool, S. Leeson, C. Fotopoulou, 2021, BJOG : an international journal of obstetrics and gynaecology.

Outcome of risk‐reducing salpingo‐oophorectomy in BRCA carriers and women of unknown mutation status

D. Oram, I. Jacobs, U. Menon, 2011, BJOG : an international journal of obstetrics and gynaecology.

Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective

I. Jacobs, U. Menon, R. Manchanda, 2009, Current opinion in obstetrics & gynecology.

A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects

D. Easton, P. Pharoah, A. Antoniou, 2015, Journal of Medical Genetics.

Robotic and Advanced Laparoscopic Surgical Training in European Gynecological Oncology Trainees.

R. Kimmig, R. Verheijen, D. Cibula, 2017, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

The Work Place Educational Climate in Gynecological Oncology Fellowships Across Europe: The Impact of Accreditation

K. Boor, N. Colombo, R. Verheijen, 2015, International Journal of Gynecologic Cancer.

Women’s Intentions to Engage in Risk-Reducing Behaviours after Receiving Personal Ovarian Cancer Risk Information: An Experimental Survey Study

J. Waller, I. Jacobs, S. Sanderson, 2019, Cancers.

Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule.

I. Jacobs, U. Menon, E. Benjamin, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer

J. Cuzick, I. Dos Santos Silva, J. Hopper, 2019, JAMA Oncology.

Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data.

Yun Yi Tan, A. Tinker, N. Le, 2019, Gynecologic oncology.

Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS

M. Parmar, I. Jacobs, U. Menon, 2021, BJOG : an international journal of obstetrics and gynaecology.

Diathermy-Induced Injury May Affect Detection of Occult Tubal Lesions at Risk-Reducing Salpingo-Oophorectomy

I. Jacobs, U. Menon, M. Burnell, 2012, International Journal of Gynecologic Cancer.

Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study

U. Menon, Naveena Singh, R. Legood, 2020, Journal of Medical Genetics.

Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention

A. Talhouk, B. Knoppers, W. Foulkes, 2022, Current oncology.

Risk‐reducing early salpingectomy and delayed oophorectomy as a two‐staged alternative for primary prevention of ovarian cancer in women at increased risk: a commentary

U. Menon, J. Piek, R. Manchanda, 2019, BJOG : an international journal of obstetrics and gynaecology.

Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II

H. Putter, B. Monk, D. Provencher, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Investigating the Impact of Ultra-Radical Surgery on Survival in Advanced Ovarian Cancer Using Population-Based Data in a Multicentre UK Study

R. Glasspool, S. Leeson, C. Fotopoulou, 2022, Cancers.

Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study

P. Pharoah, A. Antoniou, I. Jacobs, 2018, Journal of Medical Genetics.

Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC/Lynch syndrome (LS)

I. Jacobs, U. Menon, E. Benjamin, 2012, Archives of Gynecology and Obstetrics.

Randomised trial of population‐based BRCA testing in Ashkenazi Jews: long‐term secondary lifestyle behavioural outcomes

J. Wardle, I. Jacobs, U. Menon, 2022, BJOG : an international journal of obstetrics and gynaecology.

Should Opportunistic Bilateral Salpingectomy (OBS) for Prevention of Ovarian Cancer Be Incorporated Into Routine Care or Offered in the Context of a Clinical Trial?

U. Menon, M. Burnell, R. Crawford, 2016, International Journal of Gynecologic Cancer.

A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilot

L. Fallowfield, C. Turnbull, M. Hubank, 2022, Journal of Medical Genetics.

Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women

V. S. Gordeev, J. Hopper, A. Antoniou, 2018, Journal of the National Cancer Institute.

UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2

A. Antoniou, Aarti Sharma, K. Williamson, 2022, Journal of Medical Genetics.

Diagnostic Accuracy of FEC-PET/CT, FDG-PET/CT, and Diffusion-Weighted MRI in Detection of Nodal Metastases in Surgically Treated Endometrial and Cervical Carcinoma

Naveena Singh, M. Miquel, D. Koh, 2021, Clinical Cancer Research.

Cost-Effectiveness of Risk-Reducing Surgery for Breast and Ovarian Cancer Prevention: A Systematic Review

R. Legood, Li Yang, Li Yang, 2022, Cancers.

Population‐based genetic testing for cancer susceptibility genes: quo vadis?

R. Manchanda, M. Sideris, 2022, BJOG : an international journal of obstetrics and gynaecology.

Quality of Life after Risk-Reducing Hysterectomy for Endometrial Cancer Prevention: A Systematic Review

R. Legood, R. Manchanda, M. Sideris, 2022, Cancers.

Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy

F. Landoni, G. Scambia, A. Ayhan, 2022, Obstetrics and gynecology.

A commentary on population genetic testing for primary prevention: changing landscape and the need to change paradigm

R. Manchanda, F. Gaba, 2019, BJOG : an international journal of obstetrics and gynaecology.

Using Genetic Testing at Cancer Diagnosis for Breast Cancer Control

R. Legood, Li Yang, Li Yang, 2022, China CDC weekly.

Future Research Suggestions for Multigene Testing in Unselected Populations-Reply.

D. Evans, D. Buist, R. Manchanda, 2020, JAMA oncology.

The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2

Aarti Sharma, Naveena Singh, A. Mcguire, 2022, Journal of Medical Genetics.

The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer.

F. Landoni, A. Ayhan, A. Fagotti, 2021, European journal of cancer.

Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women

R. Bast, I. Jacobs, U. Menon, 2020, Cancers.

The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer.

I. Jacobs, U. Menon, R. Drapkin, 2012, Gynecologic oncology.

Cost‐effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry

Antonis C. Antoniou, John L. Hopper, Clare Turnbull, 2017, American journal of obstetrics and gynecology.

Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations

J. Wardle, I. Jacobs, U. Menon, 2016, Journal of Medical Genetics.

Population Testing for Cancer Predisposing BRCA1/BRCA2 Mutations in the Ashkenazi-Jewish Community: A Randomized Controlled Trial

J. Wardle, I. Jacobs, U. Menon, 2014, Journal of the National Cancer Institute.

Surgical pelvic anatomy in gynecologic oncology

R. Manchanda, S. Puntambekar, 2018, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

M. Parmar, I. Jacobs, U. Menon, 2021, The Lancet.

Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population

Matthew Burnell, John F. Timms, Alexey Zaikin, 2018, Clinical Cancer Research.

Bilateral seminomas in a 45X/46XY mosaic with Turner's phenotype: An unusual case of mixed gonadal dysgenesis

Parul, M. Sharma, R. Manchanda, 2003, The journal of obstetrics and gynaecology research.

Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors

D. Easton, A. Antoniou, I. Jacobs, 2020, Journal of Medical Genetics.

Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study

U. Menon, D. Evans, R. Legood, 2020, BJOG : an international journal of obstetrics and gynaecology.

Genetic screening for gynecological cancer: where are we heading?

I. Jacobs, R. Manchanda, 2016, Future oncology.

Specifying the ovarian cancer risk threshold of ‘premenopausal risk-reducing salpingo-oophorectomy’ for ovarian cancer prevention: a cost-effectiveness analysis

V. S. Gordeev, A. Antoniou, U. Menon, 2016, Journal of Medical Genetics.

Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women.

U. Menon, R. Legood, R. Manchanda, 2015, Gynecologic oncology.

Laparoscopic management of Sertoli-Leydig cell tumors of the ovary. A report of two cases.

R. Manchanda, A. Kriplani, N. Agarwal, 2001, Journal of reproductive medicine.

Giant malignant ovarian tumor: a case report.

R. Manchanda, A. Kriplani, 2005, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Patient outcomes following interval and delayed cytoreductive surgery in advanced ovarian cancer: protocol for a multicenter, international, cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative)

N. Bizzarri, P. Ramirez, R. Manchanda, 2022, International Journal of Gynecological Cancer.

Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort.

Matthew Burnell, Steven J Skates, Tim Mould, 2011, The Lancet. Oncology.

Acute pneumoperitoneum following coitus.

R. Manchanda, A. Refaie, 2005, CJEM.

Importance of serial CA125 measurements over an absolute cut‐off value for the detection of asymptomatic ovarian cancer in high‐risk patients

U. Menon, R. Manchanda, J. Dilley, 2016, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Anaphylactoid syndrome caused by amniotic fluid embolism following manual removal of placenta

R. Manchanda, A. Sriemevan, 2005, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

Screening for gynecological cancers

U. Menon, R. Manchanda, Jatinderpal Kalsi, 2013 .

Variations in gynecologic oncology training in low (LIC) and middle income (MIC) countries (LMICs): Common efforts and challenges

R. Manchanda, L. Chuang, A. Tsunoda, 2017, Gynecologic oncology reports.

Persistence of fimbrial tissue on the ovarian surface after salpingectomy

D. Oram, A. Jeyarajah, R. Manchanda, 2017, American journal of obstetrics and gynecology.

Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population

V. S. Gordeev, A. Antoniou, I. Jacobs, 2018, Journal of Medical Genetics.

Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews

J. Waller, A. Antoniou, I. Jacobs, 2022, Diagnostics.

Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study

D. Evans, R. Legood, G. Burghel, 2021, Cancers.

Preventive population genomics: The model of BRCA related cancers.

R. Manchanda, D. Reisel, C. Baran, 2021, Advances in genetics.

Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and Prevention

J. Waller, A. Antoniou, I. Jacobs, 2020, Cancers.

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study

I. Jacobs, U. Menon, A. Ryan, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome

P. Møller, H. Kitchener, U. Menon, 2019, Genetics in Medicine.

Attitude towards and factors affecting uptake of population‐based BRCA testing in the Ashkenazi Jewish population: a cohort study

I. Jacobs, U. Menon, M. Burnell, 2019, BJOG : an international journal of obstetrics and gynaecology.

Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems

J. Berkhof, J. Hopper, R. Legood, 2020, Cancers.

Prioritizing the detection of rare pathogenic variants in population screening

R. Manchanda, P. Lacaze, R. C. Green, 2023, Nature Reviews Genetics.

British Gynaecological Cancer Society recommendations for women with gynecological cancer who received non-standard care during the COVID-19 pandemic

J. Ledermann, S. Ghaem-Maghami, C. Fotopoulou, 2021, International Journal of Gynecological Cancer.

COVID‐19 and the impact on gynecologic cancer care

S. Ghaem-Maghami, R. Manchanda, S. Sundar, 2021, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Randomised trial of population‐based BRCA testing in Ashkenazi Jews: long‐term outcomes

I. Jacobs, U. Menon, M. Burnell, 2019, BJOG : an international journal of obstetrics and gynaecology.

Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial

U. Menon, R. Manchanda, 2016, BJOG : an international journal of obstetrics and gynaecology.

Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis

R. Legood, R. Manchanda, O. Blyuss, 2023, Cancers.

The DNA methylome of cervical cells can predict the presence of ovarian cancer

M. Widschwendter, M. Zikan, M. Kristiansen, 2022, Nature Communications.

Collaborations in gynecologic oncology education and research in low- and middle- income countries: Current status, barriers and opportunities

T. Rebbeck, E. Trimble, J. Berek, 2018, Gynecologic oncology reports.

Lynch syndrome screening in gynaecological cancers: results of an international survey with recommendations for uniform reporting terminology for mismatch repair immunohistochemistry results

C. Gilks, T. Bosse, M. Arends, 2019, Histopathology.

Recruitment, adherence, and retention of endometrial cancer survivors in a behavioural lifestyle programme: the Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomised pilot trial

M. Burnell, R. Beeken, D. Koutoukidis, 2017, BMJ Open.

Variation in outcome reporting in studies of fertility‐sparing surgery for cervical cancer: A systematic review

S. Iliodromiti, R. Manchanda, M. Sideris, 2022, BJOG : an international journal of obstetrics and gynaecology.

Setting the Threshold for Surgical Prevention in Women at Increased Risk of Ovarian Cancer

U. Menon, R. Manchanda, 2017, International Journal of Gynecologic Cancer.

Cost-Effectiveness of Genetic Testing for All Women Diagnosed with Breast Cancer in China

R. Legood, Li Yang, R. Manchanda, 2022, Cancers.

Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

I. Jacobs, U. Menon, A. Ryan, 2016, PLoS ONE.

The Need for More Workshops in Laparoscopic Surgery and Surgical Anatomy for European Gynaecological Oncology Trainees: A Survey by the European Network of Young Gynaecological Oncologists

M. Gultekin, D. Haidopoulos, I. Zapardiel, 2013, International Journal of Gynecologic Cancer.

Histological confirmation of breast cancer registration and self-reporting in England and Wales: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening

I. Jacobs, U. Menon, A. Ryan, 2012, British Journal of Cancer.

Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UK

S. Dobbs, R. Legood, S. Kehoe, 2023, Cancers.

Diet and exercise in uterine cancer survivors (DEUS pilot) - piloting a healthy eating and physical activity program: study protocol for a randomized controlled trial

M. Burnell, R. Beeken, D. Koutoukidis, 2016, Trials.

Evidence of stage-shift in women diagnosed with ovarian cancer during Phase 2 of the UK Familial Ovarian Cancer Screening Study (UKFOCSS)

I. Jacobs, U. Menon, A. Ryan, 2016 .

Predictors of complications in gynaecological oncological surgery: a prospective multicentre study (UKGOSOC—UK gynaecological oncology surgical outcomes and complications)

U. Menon, A. Ryan, M. Burnell, 2014, British Journal of Cancer.

SOCQER-2 Study: Preliminary analysis of multicentre recruitment after surgery in advanced ovarian cancer

S. Leeson, C. Fotopoulou, C. Cummins, 2016 .

Commentary on changing the risk threshold for surgical prevention of ovarian cancer

U. Menon, R. Legood, R. Manchanda, 2017, BJOG : an international journal of obstetrics and gynaecology.

Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK

U. Menon, R. Crawford, M. Tischkowitz, 2015, Familial Cancer.

Factors influencing uptake and timing of risk reducing salpingo‐oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis

D. Oram, I. Jacobs, I. Jacobs, 2012, BJOG : an international journal of obstetrics and gynaecology.

Population Based Testing for Primary Prevention: A Systematic Review

R. Manchanda, F. Gaba, 2018, Cancers.

Tumour markers and screening

Usha Menon, Ian J. Jacobs, Ranjit Manchanda, 2000 .

Population based germline testing for primary cancer prevention

R. Legood, R. Manchanda, 2018, Oncotarget.

Benchmarking of surgical complications in gynaecological oncology: prospective multicentre study

U. Menon, A. Ryan, M. Burnell, 2016, BJOG : an international journal of obstetrics and gynaecology.

Co-Creation of Breast Cancer Risk Communication Tools and an Assessment of Risk Factor Awareness: A Qualitative Study of Patients and the Public in India

A. Antoniou, A. Gentry-Maharaj, R. Manchanda, 2023, Cancers.

Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study

Stephen S. Taylor, J. Brenton, J. Ledermann, 2023, International Journal of Gynecological Cancer.

Differential diagnosis of adnexal masses: sequential use of the risk of malignancy index and HistoScanning, a novel computer‐aided diagnostic tool

U. Menon, R. Manchanda, H. Bleiberg, 2012, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Robotic and Advanced Laparoscopic Surgical Training in European Gynecological Oncology Trainees

R. Kimmig, R. Verheijen, D. Cibula, 2017, International Journal of Gynecologic Cancer.

Impact of a decision aid about stratified ovarian cancer risk-management on women’s knowledge and intentions: a randomised online experimental survey study

J. Wardle, J. Waller, I. Jacobs, 2017, BMC Public Health.

Gynecologic Oncology Training Systems in Europe: A Report From the European Network of Young Gynaecological Oncologists

M. Gultekin, D. Haidopoulos, I. Zapardiel, 2011, International Journal of Gynecologic Cancer.

Special Issue “Gynaecological Cancers Risk: Breast Cancer, Ovarian Cancer and Endometrial Cancer”

R. Manchanda, 2022, Cancers.

Jewish cultural and religious factors and uptake of population‐based BRCA testing across denominations: a cohort study

J. Wardle, I. Jacobs, U. Menon, 2021, BJOG : an international journal of obstetrics and gynaecology.

Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis.

R. Legood, A. Brentnall, Li Yang, 2023, American journal of obstetrics and gynecology.

Final results of 4-monthly screening in the UK Familial Ovarian Cancer Screening Study (UKFOCSS Phase 2).

I. Jacobs, U. Menon, S. Skates, 2013 .

Change in stage distribution observed with annual screening for ovarian cancer in BRCA carriers

J. Mackay, R. Manchanda, L. Fraser, 2009, Journal of Medical Genetics.

A quantitative performance study of two automatic methods for the diagnosis of ovarian cancer

Manuel A. Vázquez, Ian Jacobs, Alexey Zaikin, 2018, Biomed. Signal Process. Control..

Post-recurrence survival in patients with cervical cancer.

G. Scambia, A. Ayhan, D. Cibula, 2021, Gynecologic oncology.

Ovarian Cancer Screening There May Be Light at the End of the Tunnel?

D. Cibula, R. Manchanda, 2016, International Journal of Gynecologic Cancer.

The annual recurrence risk model for tailored surveillance strategy in 1 cervical cancer patients

Weinberger, F. Landoni, A. Ayhan, 2021 .

Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population

M. Parmar, I. Jacobs, U. Menon, 2018, Clinical Cancer Research.

Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule.

I. Jacobs, U. Menon, E. Benjamin, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing

J. Wardle, I. Jacobs, U. Menon, 2014, Journal of the National Cancer Institute.

Commentary on changing the risk threshold for surgical prevention of ovarian cancer

A. Antoniou, R. Manchanda, Usha Menon, 2017, BJOG : an international journal of obstetrics and gynaecology.

Analysis of Anxiety, Depression and Fear of Progression at 12 Months Post-Cytoreductive Surgery in the SOCQER-2 (Surgery in Ovarian Cancer—Quality of Life Evaluation Research) Prospective, International, Multicentre Study

R. Glasspool, R. Manchanda, Satyam Kumar, 2023, Cancers.

Screening and prevention of ovarian cancer.

R. Manchanda, Usha Menon, M. Sideris, 2024, The Medical journal of Australia.

Differential diagnosis of adnexal masses: sequential use of the risk of malignancy index and HistoScanning, a novel computer‐aided diagnostic tool

U. Menon, R. Manchanda, E. Vaes, 2012, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Combined population genomic screening for three high-risk conditions in Australia: a modelling study

Z. Ademi, R. Manchanda, J. Tiller, 2023, EClinicalMedicine.

Utility Scores for Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy: Mapping to EQ-5D

R. Manchanda, Z. Sadique, S. Oxley, 2024, Cancers.

Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study

R. Legood, R. Manchanda, Munaza Ahmed, 2023, BJOG : an international journal of obstetrics and gynaecology.

Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK

U. Menon, R. Crawford, M. Tischkowitz, 2015, Familial Cancer.

Prognosis Following Surgery for Recurrent Ovarian Cancer and Diagnostic Criteria Predictive of Cytoreduction Success: A Systematic Review and Meta-Analysis

N. Bizzarri, R. Manchanda, B. Refky, 2023, Diagnostics.

Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer.

M. Burnell, R. Manchanda, Usha Menon, 2024, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian Cancer.

R. Legood, B. Norquist, R. Manchanda, 2024, Journal of the National Comprehensive Cancer Network : JNCCN.

Mathematical Models to Discriminate Between Benign and Malignant Adnexal Masses: Potential Diagnostic Improvement Using Ovarian HistoScanning

U. Menon, R. Manchanda, H. Bleiberg, 2010, International Journal of Gynecologic Cancer.

British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for genetic testing in epithelial ovarian cancer in the United Kingdom.

M. Jimenez-Linan, R. Manchanda, J. Bálega, 2024, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.